![Christopher Cain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Cain
Directeur/Membre du Conseil chez
COGENT BIOSCIENCES, INC.
Fortune : - $ au 31/05/2026
Profil
Christopher Cain is currently an Independent Director at Cogent Biosciences, Inc. since 2020.
Since 2024, serving as Director at Jade Biosciences, Inc. (United States).
Beginning in 2025, holds positions as Independent Director at Damora Therapeutics, Inc., Director at Viridian Therapeutics, Inc., and Independent Director at Jade Biosciences, Inc. Former roles include Vice President at Samsara BioCapital LP from 2019 to 2020 and Senior Associate at Apple Tree Venture Management LLC from 2016 to 2019.
Education includes an undergraduate degree from the University of California, Santa Barbara in 2004 and a doctorate from The University of California, San Francisco in 2010.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Christopher Cain
| Sociétés | Poste | Début |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Directeur/Membre du Conseil | 06/07/2020 |
| VIRIDIAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/03/2025 |
| JADE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 28/04/2025 |
| DAMORA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/11/2025 |
Anciens postes connus de Christopher Cain
| Sociétés | Poste | Fin |
|---|---|---|
Samsara BioCapital LP
 Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | 01/02/2020 |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Analyste en capital-investissement | 28/02/2019 |
Formation de Christopher Cain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Samsara BioCapital LP
Samsara BioCapital LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
